Larry M. Simonsmeier Writing Award
The American Society for Pharmacy Law (ASPL) is a nationwide organization with the purposes of: (i) furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues ("Pharmacy Law"); (ii) communicating accurate legal educational information; and (iii) providing education opportunities for pharmacists, attorneys, and others who are interested in Pharmacy Law.
ASPL recognizes outstanding scholarship related to Pharmacy Law with the Simonsmeier Award. The Award recognizes an outstanding paper relating to the interests of ASPL published during the prior two years (2012-2014). The 2015 Award includes an honorarium plus support for travel to the ASPL Developments in Pharmacy Law Seminar XXVI in Miami, Florida, November 12-15, 2015.
The Award is named in honor of the late Larry Simonsmeier (1944-2009), who was a pharmacist and attorney, professor and dean of Washington State University College of Pharmacy, president of ASPL, and editor of the Rx Ipsa Loquitur for more than twenty years.
Papers related to Pharmacy Law, as defined above, published in or accepted for publication in any English-language peer-reviewed journal (including law reviews) during the period from January 2013 through December 2014 are eligible. Interested parties are invited to nominate published papers written by themselves or other authors. Authors may submit manuscripts that are in press.
Submission of Nominations
Nominations should provide the name, address, daytime telephone number, and e-mail address of the nominator, a reprint of the full paper, and a complete journal citation for the paper being nominated. If an author is submitting a manuscript that is in press, the copy of the manuscript should be accompanied by documentation from the journal editor of the status of the paper, and should include contact information for the journal editor. The deadline for submission of nominations for the Larry M. Simonsmeier Award is June 30, 2015.
Nominations should be addressed to:
Education & Scholarship Committee
Questions may be directed to ASPL at:
December 14, 2014
Cadden, Chin charged with homicide by federal prosecutors as part of RICO indictment arising from meningitis outbreak
On December 14, DOJ officials held a press conference in Boston announcing the arrests on criminal charges by federal agents of 11 individuals associated with the New England Compounding Center (NECC); 3 other individuals were also charged. According to remarks by Acting Associate Attorney General Stuart Delery, the criminal investigation of the meningitis outbreak associated with fungus-tainted injectable drugs produced by NECC “uncovered widespread, sustained, and systematic unlawful conduct at NECC that, as alleged in the indictment, was not only condoned, but was explicitly directed by management and senior pharmacists. This conduct included grossly insufficient and unsanitary production practices, as well as fake prescriptions that were used to mislead regulators [emphasis in original transcript].” Attorney General Eric Holder issued a statement echoing Delery: “As alleged in the indictment, these employees knew they were producing their medication in an unsafe manner and in insanitary conditions, and authorized it to be shipped out anyway, with fatal results.”
Among the 131 counts in the indictment, Barry Cadden, owner of NECC, and Glenn A. Chinn, NECC’s supervising pharmacist, were charged with 25 acts of second-degree murder in Florida, Indiana, Maryland, Michigan, North Carolina, Tennessee, and Virginia. Charges against 12 other individuals included racketeering, mail fraud, conspiracy, contempt, structuring, and violations of the FDCA. [USDOJ, 14 indicted in connection with New England Compounding Center and nationwide fungal meningitis outbreak. Justice News 2014 Dec 17; http://1.usa.gov/1sFM0NI]
SAVE THE DATE!
March 27-30, 2015
ASPL Pharmacy Law Track